Publication
Title
Recommendations for reporting morbid events after heart valve surgery
Author
Institution/Organisation
Working Group Infection, Thrombosis, Embolism and Bleeding of the Society for Heart Valve Disease
Abstract
Major reasons for the considerable heterogeneity among published results of heart valve surgery are inconsistency in follow up techniques, reporting systems and classification of adverse events. The present recommendations are intended to harmonize the presentation of clinical material in order to improve comparison of data from different sources for the analysis of pooled data. The quality of an observational study is largely, if not entirely, due to the follow up technique, which may be graded according to six categories: Self-reporting of adverse events/wellbeing by the patients may be classified excellent; if the information is gathered and re-checked at shortterm intervals. Data obtained from in-hospital or outpatient examinations by qualified examiners at least twice a year or other personal contact through qualified examiners may be regarded as sufficient, if the results are re-checked by contacting the treating home physician. All other follow up techniques may be regarded as inappropriate. Consequences of complications are entirely dependent on severity and possible sequelae. It is therefore recommended to grade any reported complication according to its severity by utilizing a score system. Embolisms are best categorized by utilizing the performance status scale. Bleeding events may be categorized according to severity as fatal, major (requiring hospital transmission with transfusion, surgery or with permanently increased disability) or minor (not requiring hospital admission, surgery or transfusion). In some cases it will remain unclear whether an event was primarily embolic or hemorrhagic. These complications should be summarized as not categorized. The reporting of morbid events due to thrombosis, embolism and bleeding should go along with information regarding the quality of antithrombotic management.
Language
English
Source (journal)
Journal of heart valve disease. - New York, N.Y.
Publication
New York, N.Y. : 2005
ISSN
0966-8519
Volume/pages
14 :1 (2005) , p. 1-7
ISI
000228632900002
UAntwerpen
Faculty/Department
Project info
Aortic valve degeneration: cell-biological aspects and clinical results after aortic valve replacement.
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identifier
Creation 15.01.2010
Last edited 25.05.2022
To cite this reference